CTKB R&D to Revenue
Cytek Biosciences Inc · R&D to Revenue
CTKB R&D to Revenue
Latest reported20.23%period ending
CTKB Quarterly R&D/Revenue (16.77% → 20.23%)
Latest values, visible window
High-resolution chart · PNG
CTKB r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 20.2347% | |
| 21.7605% | |
| 14.422% | |
| 17.1266% | |
| 19.3544% | |
| 23.458% | |
| 16.9166% | |
| 19.1883% | |
| 21.4535% | |
| 21.8368% | |
| 18.6647% | |
| 23.2729% | |
| 24.422% | |
| 26.8928% | |
| 20.1651% | |
| 21.3702% | |
| 21.0065% | |
| 22.8867% | |
| 18.193% | |
| 17.6809% | |
| 20.3696% | |
| 20.9871% | |
| 14.3212% | |
| 13.4523% | |
| 15.2383% | |
| 16.7667% |